| Biologic Therapy |
0 |
0.8 |
| Non-Hodgkin Lymphoma (NHL) |
0 |
0.8 |
| CAR-T |
0 |
0.96 |
| B-Cell Lymphoma |
0 |
1 |
| Lymphoma |
0 |
0.31 |
| Toxicology |
0 |
0.3 |
| Clinical Research |
0 |
0.21 |
| Refractory |
0 |
0.21 |
| Healthcare and Medical Technology |
0 |
0.2 |
| Neutropenia |
0 |
0.2 |
| Anemia |
0 |
0.1 |
| Antigens |
0 |
0.1 |
| Blood-Brain Barrier |
0 |
0.09 |
| Stem Cell Research and Therapy |
0 |
0.09 |